Measure 180 – Rheumatoid Arthritis (RA): Glucocorticoid Management

Audit Criteria

When we’re reviewing your clinicians’ data, it may be helpful to know what we are looking for in order for us to verify to CMS that your data is accurate and complete. Measure 180 requires documentation that a patient with a diagnosis of rheumatoid arthritis who have been assessed for glucocorticoid use and, for those on prolonged doses (>6 months in duration) of prednisone ≥10 mg daily (or equivalent) with improvement or no change in activity, has a documented glucocorticoid management plan within 12 months.

This documentation may be found in the patient’s medical record. This measure may only be reported once per year per patient. The relevant document should be made available to the auditor for the patient requested.

 

What do I need to show?

The auditor will need to see that the patient has a glucocorticoid management plan in place and documented in the medical record. For patients on prolonged doses of prednisone or its equivalent, the dosage should be documented as ≤10 mg per day.